Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FAKMX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,783
Award facts
- Contract value 100% obligated
- $12,782.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,782.56 by the Defense Logistics Agency on January 16, 2026, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract carries a firm fixed-price structure with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 20, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
The Defense Logistics Agency Medical Supply Chain relies on such delivery orders to fulfill critical pharmaceutical requirements across military treatment facilities and veteran healthcare programs. Humira is a widely-used biologic immunosuppressant medication commonly employed in the treatment of autoimmune conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. AmerisourceBergen's extensive federal contracting history and established infrastructure as a primary vendor for DLA underscore the company's capability to efficiently fulfill government pharmaceutical procurement needs across multiple therapeutic domains. This award continues the company's significant role in supplying essential medications to the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FAKMX?
SPE2DR26FAKMX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FAKMX worth?
The government has obligated $12,783 on SPE2DR26FAKMX.
Is contract SPE2DR26FAKMX an order under another contract?
Yes. SPE2DR26FAKMX is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKMX competed?
The extent of competition for SPE2DR26FAKMX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award